Drugs / Wosulin N
Wosulin N
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00772265 | Sep 2010 → Mar 2011 | diabetes mellitus | Wockhardt | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Wosulin N | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00772265 ↗ |
| Known as | Isophane insulin | “Wosulin N, Isophane insulin for injection (Recombinant Human Insulin)(100 IU/mL), cartridges 3.0 mL” NCT00772265 ↗ |
| Known as | Recombinant Human Insulin | “Wosulin N, Isophane insulin for injection (Recombinant Human Insulin)(100 IU/mL), cartridges 3.0 mL” NCT00772265 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant Human Insulin” NCT00772265 ↗ |
| Route | Subcutaneous | “given Subcutaneously” NCT00772265 ↗ |